Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus
- PMID: 8599211
- DOI: 10.1006/viro.1996.0113
Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus
Abstract
We amplified by polymerase chain reaction the heavy and light chain antibody genes of two mouse hybridomas secreting neutralizing monoclonal antibodies (MAbs) to the G1 or G2 envelope proteins of Hantaan virus, cloned them into the phagemid vector pComb3, and expressed them in bacteria to yield Fab fragments. Expressed Fab fragments had the same antigenic specificities for Hantaan and Seoul viruses as the complete parent MAbs and were able to neutralize Hantaan virus in plaque-reduction neutralization assays. The authentic MAb to G2 (HCO2) could passively protect hamsters from challenge with Hantaan virus when neutralizing antibody titers of at least 1:10 were detected in the animals' sera just prior to challenge. In contrast, although 1:10 neutralization titers were also detected in hamsters receiving passively transferred, Escherichia coli-expressed HCO2 Fab, these animals were not protected from infection with Hantaan virus. Similarly, passive transfer of the HCO2 Mab on Days 1 through 4 after infection prevented antigen deposition in hamster lungs and kidneys but passive transfer of the recombinant HCO2 Fab did not. The results suggest that although neutralization by IgG antibodies correlates with protection in hamsters, the same may not be true for neutralizing Fab fragments.
Similar articles
-
Chimeric macaque/human Fab molecules neutralize simian immunodeficiency virus.Virology. 1995 Mar 10;207(2):495-502. doi: 10.1006/viro.1995.1109. Virology. 1995. PMID: 7886953
-
Generation of an HFRS patient-derived neutralizing recombinant antibody to Hantaan virus G1 protein and definition of the neutralizing domain.J Med Virol. 2003 Jan;69(1):99-107. doi: 10.1002/jmv.10259. J Med Virol. 2003. PMID: 12436484
-
Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library.J Immunol. 1995 Jun 15;154(12):6355-64. J Immunol. 1995. PMID: 7759873
-
Recombinant monoclonal antibody technology.Transfus Clin Biol. 2002 Jan;9(1):15-22. doi: 10.1016/s1246-7820(01)00210-5. Transfus Clin Biol. 2002. PMID: 11889896 Review.
-
[Neutralizing human antibody specific for human cytomegalovirus in E. coli expression system].Nihon Rinsho. 1998 Jan;56(1):161-6. Nihon Rinsho. 1998. PMID: 9465683 Review. Japanese.
Cited by
-
Puumala orthohantavirus: prevalence, biology, disease, animal models and recent advances in therapeutics development and structural biology.Front Immunol. 2025 May 8;16:1575112. doi: 10.3389/fimmu.2025.1575112. eCollection 2025. Front Immunol. 2025. PMID: 40406115 Free PMC article. Review.
-
Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.Biomed Res Int. 2015;2015:793257. doi: 10.1155/2015/793257. Epub 2015 Jul 21. Biomed Res Int. 2015. PMID: 26266264 Free PMC article. Review.
-
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS).Vaccine. 2013 Sep 13;31(40):4314-21. doi: 10.1016/j.vaccine.2013.07.025. Epub 2013 Jul 24. Vaccine. 2013. PMID: 23892100 Free PMC article.
-
A lethal disease model for hantavirus pulmonary syndrome in immunosuppressed Syrian hamsters infected with Sin Nombre virus.J Virol. 2014 Jan;88(2):811-9. doi: 10.1128/JVI.02906-13. Epub 2013 Nov 6. J Virol. 2014. PMID: 24198421 Free PMC article.
-
A global perspective on hantavirus ecology, epidemiology, and disease.Clin Microbiol Rev. 2010 Apr;23(2):412-41. doi: 10.1128/CMR.00062-09. Clin Microbiol Rev. 2010. PMID: 20375360 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources